Community Research and Development Information Service - CORDIS

Leveraging a novel platform technology to develop a first-in-class immunotherapy for Celiac Disease

From 2018-09-01 to 2019-02-28, ongoing project

Project details

Total cost:

EUR 71 429

EU contribution:

EUR 50 000

Coordinated in:

Belgium

Call for proposal:

H2020-SMEInst-2018-2020-1See other projects for this call

Funding scheme:

SME-1 - SME instrument phase 1

Objective

Coordinator

ALLERO THERAPEUTICS
Belgium

EU contribution: EUR 50 000


ONDERSTRAAT 7/211
9070 GENT
Belgium
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)

Contact the organisation

Follow us on: RSS Facebook Twitter YouTube Managed by the EU Publications Office Top